metronidazole has been researched along with brl 28500 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrew, JH; Downes, J | 1 |
Blair, JE; Cohen, Z; Devlin, HR; McLeod, RS | 1 |
Hulla, FW; Maslak, A; Schulze, B; Schwigon, CD | 1 |
Clay, PG; Freeman, C; Glaros, A; Graham, MR; Lamp, KC; Lindsey, CC | 1 |
Gurkan, E; Hutton-Thomas, R; Lakticová, V; Meyer, M; Rice, LB | 1 |
2 trial(s) available for metronidazole and brl 28500
Article | Year |
---|---|
Ticarcillin/clavulanic acid (Timentin) compared to metronidazole/netilmicin in preventing postoperative infection after elective colorectal surgery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Clavulanic Acids; Clinical Trials as Topic; Colon; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Middle Aged; Netilmicin; Penicillins; Premedication; Random Allocation; Rectum; Surgical Wound Infection; Ticarcillin | 1987 |
Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older mal
Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Ceftriaxone; Clavulanic Acids; Cost Savings; Diabetic Foot; Drug Administration Schedule; Drug Combinations; Drug Costs; Drug Therapy, Combination; Hospital Costs; Hospitalization; Humans; Male; Metronidazole; Prospective Studies; Ticarcillin; Treatment Outcome | 2004 |
3 other study(ies) available for metronidazole and brl 28500
Article | Year |
---|---|
Susceptibility of 114 isolates of the Bacteroides fragilis group to imipenem and eight other antimicrobial agents.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Imipenem; Metronidazole; Microbial Sensitivity Tests; Penicillins; Ticarcillin | 1988 |
Timentin in the treatment of nosocomial bronchopulmonary infections in intensive care units.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bronchitis; Clavulanic Acids; Critical Care; Cross Infection; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Middle Aged; Penicillin Resistance; Penicillins; Pneumonia; Ticarcillin | 1986 |
Antibiotic-induced enterococcal expansion in the mouse intestine occurs throughout the small bowel and correlates poorly with suppression of competing flora.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Clavulanic Acids; Clindamycin; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Escherichia coli; Green Fluorescent Proteins; Intestine, Small; Metronidazole; Mice; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Ticarcillin | 2006 |